Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.540
+0.090 (3.67%)
Dec 20, 2024, 4:00 PM EST - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $718.13 million as of December 20, 2024. Its market cap has increased by 157.80% in one year.
Market Cap
718.13M
Enterprise Value
307.76M
1-Year Change
157.80%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $718.13M, a decrease of -61.36%. That is a compound annual growth rate of -24.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 718.13M | 123.91% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 718.22M |
| Avanos Medical | 713.88M |
| Oculis Holding AG | 713.48M |
| Relay Therapeutics | 713.05M |
| Kura Oncology | 697.54M |
| Immunome | 691.58M |
| Evolus | 688.30M |
| Bioventus | 687.67M |